April Lewis, GM of Hū, part of Real Chemistry

Most recent articles by April Lewis, GM of Hū, part of Real Chemistry

March 26, 2021

12:00 pm

DCTs or hybrid trials support patient needs in ways that traditional clinical trials have not been able to meet.

Talking Medicines’ Jo Halliday discussed how the pharmaceutical sector can better understand the voice of the patient.

Learn about Intouch Group’s journey to foster I+D so that its inclusive culture translates into inclusive healthcare marketing.

Any EHR provider delivering a quality solution should be able to answer these six questions.

Veradigm VP Damon Basch sits down to discuss strategy for point of care media in the age of Covid-19.